Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76073 | 0.88 | ACHE (0.59) | IDO1RECQLALDH1A1GAAACHE | |
| SCHEMBL12337765 | 0.87 | IDO1 (0.48) | IDO1RECQLALDH1A1GAAACHE | |
| SCHEMBL14732513 | 0.86 | IDO1 (0.44) | IDO1RECQLALDH1A1GAAACHE | |
| SCHEMBL8336169 | 0.85 | IDO1 (0.47) | IDO1RECQLALDH1A1GAACYP1A2 | |
| SCHEMBL11239117 | 0.85 | IDO1 (0.47) | IDO1RECQLALDH1A1GAAACHE | |
| SCHEMBL13870175 | 0.83 | RECQL (0.53) | IDO1RECQLALDH1A1GAAMAPT | |
| SCHEMBL19818189 | 0.83 | IDO1 (0.45) | IDO1RECQLALDH1A1GAACYP1A2 | |
| SCHEMBL25464628 | 0.82 | BCHE (0.61) | IDO1RECQLALDH1A1GAAACHE | |
| SCHEMBL2802287 | 0.82 | IDO1 (0.54) | IDO1RECQLALDH1A1GAAACHE | |
| SCHEMBL9866115 | 0.81 | CYP1A2 (0.52) | IDO1RECQLALDH1A1GAACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371674-A | Preparation method of donor-acceptor type metal organic framework photocatalyst and application of photocatalytic amine oxide/thioether | 长沙理工大学 | 2025-01-28 | — | — | CN | claimed |
| CN-119371674-A | Preparation method of donor-acceptor type metal organic framework photocatalyst and application of photocatalytic amine oxide/thioether | 长沙理工大学 | 2025-01-28 | — | — | CN | disclosed |
| CN-119318976-A | Doped metal halide perovskite photocatalyst and preparation method and application thereof | 东华理工大学 | 2025-01-17 | — | — | CN | disclosed |
| EP-4139281-B1 | SULFUR EXTRUSION FROM DISULFIDES BY CARBENES | UNIV HEIDELBERG (DE) | 2024-05-08 | — | — | EP | disclosed |
| CN-116981659-A | Process for preparing enantiomerically enriched (2Z) -2- (phenylimino) -1, 3-thiazolidin-4-one sulfoxide derivatives | 拜耳公司 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023095615-A1 | EPOXY RESIN COMPOSITION, CURED PRODUCT THEREOF, AND LAMINATE | DIC株式会社 | 2023-06-01 | — | — | WO | disclosed |
| US-20230151054-A1 | SULFUR EXTRUSION FROM DISULFIDES BY CARBENES | Universität Heidelberg (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151054-A1 | SULFUR EXTRUSION FROM DISULFIDES BY CARBENES | Universität Heidelberg (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151054-A1 | SULFUR EXTRUSION FROM DISULFIDES BY CARBENES | Universität Heidelberg (DE) | 2023-05-18 | — | — | US | disclosed |
| CN-112608257-B | Synthesis method of sulfoxide compound | 新疆大学 | 2023-04-07 | — | — | CN | disclosed |
| EP-0309953-A1 | 5-Substituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-isoxazolidines | FISONS CORPORATION (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4505860-A | Cyclic keto-butyraldehydes a process for their preparation, and their use in the preparation of cyclic diisocyanates | BAYER AKTIENGESELLSCHAFT (DE) | 1985-03-19 | — | — | US | disclosed |
| EP-0100479-B1 | 3-(AMINOMETHYL)-1-(3-AMINOPROPYL-1-METHYL)-4-METHYL CYCLOHEXANE, PROCESS FOR ITS PREPARATION AND ITS USE | BAYER AG (DE) | 1985-03-13 | — | — | EP | disclosed |
| US-4487966-A | 3-Aminomethyl-1-(3-aminopropyl-1-methyl)-4-methylcyclohexane, a process for its preparation and its use | BAYER AKTIENGESELLSCHAFT (DE) | 1984-12-11 | — | — | US | disclosed |
| EP-0074561-B1 | CYCLIC CETO-BUTYRALDEHYDES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE PREPARATION OF CYCLIC DIISOCYANATES | BAYER AG (DE) | 1984-11-21 | — | — | EP | disclosed |
| EP-0100479-A1 | 3-(Aminomethyl)-1-(3-aminopropyl-1-methyl)-4-methyl cyclohexane, process for its preparation and its use | BAYER AG (DE) | 1984-02-15 | — | — | EP | disclosed |
| EP-0008763-B1 | AMINOMETHYL-CYCLODODECANES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTICORROSIVES | BAYER AG (DE) | 1981-04-01 | — | — | EP | disclosed |
| US-4251462-A | REACTING 1,5,9-CYCLODODECATRIENE WITH CARBON MONOXIDE AND HYDROGEN, REMOVING CATALYST, REACTING WITH HYDROGEN AND AMMONIA | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-17 | — | — | US | disclosed |
| EP-0008763-A1 | Aminomethyl-cyclododecanes, a process for their preparation and their use as anticorrosives | BAYER AG (DE) | 1980-03-19 | — | — | EP | disclosed |
| US-4120866-A | REACTING AN AROMATIC COMPOUND WITH A SULFOXIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151054-A1 | SULFUR EXTRUSION FROM DISULFIDES BY CARBENES | TST, CBS, CTH | IDO1 1812/4885RECQL 3473/4885ALDH1A1 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.